News and Events

Upcoming Events

Another proof point from CIRM-supported research October 7, 2026
When Alameda-based biotech company and CIRM awardee Scribe Therapeutics raised over $155 million from a recent IPO, it became the latest in a series of companies developing CIRM-supported therapies that have gone public or netted significant follow-on funding and investment. That’s good news for Californians whose tax dollars support the companies’ work. While biotech IPOs […]
Cured of sickle cell disease, Christelle Salomon builds trust in clinical trials September 30, 2026
By Emily Moskal In her first year as a newborn, Christelle Salomon was diagnosed with sickle cell disease. The fact that, as a baby, Salomon would only stop crying from pain at the peak of a swing on the swing set tipped off one of her six siblings to the debilitating illness that Salomon would […]
Former CIRM trainee Mercedes Paredes goes full circle September 25, 2026
When Mercedes Paredes was a young clinical fellow at the University of California, San Francisco, she knew she wanted to spend her career better understanding the origins of – and possible treatments for – neuropsychiatric diseases. She didn’t know how to get started. That’s where a training grant from the California Institute for Regenerative Medicine […]